NEU 3.50% $14.05 neuren pharmaceuticals limited

Share Price, page-2617

  1. 5,815 Posts.
    lightbulb Created with Sketch. 335
    You would have to ask the board that question.

    If they just license out their tech and develop new tech/indications for licensing then I would expect a lot paid back to shareholders.

    If they decide to run all the way to roll
    out, with future programs then it is likely a long time before dividends being paid.

    IMO

    .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.